FDA to weigh easing limits on unproven peptides Regeneration or Risk? A Narrative Review of BPC 157 for Musculoskeletal Healing Current Reviews in Musculoskeletal Medicine Springer Nature Link BPC 157: The peptide with big claims and scant evidence STAT The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University FDA takes first step in possible reversal of ban on some peptides The Washington Post